Effects of 2,2'(methylenediimino)bis-1,3,4-thiadiazole (NSC-143019) on tumor growth and immune responses in mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003959:Diamines / Q000494:pharmacology / Q000627:therapeutic use; D005856:Germ-Free Life; D006087:Graft vs Host Reaction; D006367:HeLa Cells; D006386:Hemagglutination Tests; D006462:Hemolytic Plaque Technique; D007109:Immunity / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007939:Leukemia L1210 / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008813:Mice, Inbred ICR; D008815:Mice, Inbred Strains; D008937:Mitomycins / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy; D013830:Thiadiazoles / Q000494:pharmacology / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D003959:Diamines; D007166:Immunosuppressive Agents; D008937:Mitomycins; D009539:Nicotinic Acids; D013830:Thiadiazoles; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate